Published Date: 17 Mar 2023
FNB Fetal Radiology, ou FNB du National Board of Fetal Radiology, est un programme doctoral appelé FNB in Fetal Radiology.
Read Full NewsExplore anticipated FDA decisions on groundbreaking neurology drugs in 2026, shaping treatment options for various neurologic conditions.
As part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Alzheimer disease and dementia that may impact care.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 2, 2026.
Psychiatry in 2025: Year in Review
Gastroenterology in 2025: Year in Review
Weight-Adjusted Waist Index Predicts Cardiovascular Risk in Patients with T2D
1.
Weight loss trial reports success for breast cancer patients at one year mark
2.
What Kate Middleton Reminds Us About the Role of Privacy in Healing.
3.
Can taking vitamin D supplements every day lower the mortality rate from cancer?
4.
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement
5.
'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
1.
Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights
2.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
3.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
4.
All You Need To Know About Melanoma Maligna: Causes, Symptoms & Treatment
5.
The Rise of Immunotherapy: New Advances in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation